Overview
Kiyohiko Angata practices practicing medicine in Hachioji, Japan.
Their clinical expertise encompasses Hepatitis B, Hepatitis, Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), and Cholangiocarcinoma (Bile Duct Cancer).
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kiyohiko Angata
Is Kiyohiko Angata a top-rated expert for Hepatitis B?
MediFind is an objective health platform that identifies experts based on real-world data. Kiyohiko Angata is classified as an Experienced expert for Hepatitis B, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kiyohiko Angata participate in research or clinical trials?
Yes. Kiyohiko Angata has published 22 articles and abstracts on conditions like Hepatitis B. You can view a list of Kiyohiko Angata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cholangiocarcinoma (Bile Duct Cancer)
- HepatitisAngata isExperienced. Learn about Hepatitis.
- Hepatitis BAngata isExperienced. Learn about Hepatitis B.
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)